Researchers have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed the tumor immune microenvironment ...
FlowMatrix, an innovative artificial intelligence (AI)-guided high-throughput platform, is allowing rapid assessment of the effects of novel drug pairings in living cells and identifying those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results